Literature DB >> 24150537

Septal penetration in iodine-123 metaiodobenzylguanidine cardiac sympathetic imaging using a medium-energy collimator.

Yusuke Inoue1, Yutaka Abe, Yuji Asano, Kei Kikuchi, Takahiro Iizuka, Kazutoshi Nishiyama.   

Abstract

BACKGROUND: Septal penetration of high-energy photons affects the estimation of the heart-to-mediastinum (H/M) ratio in cardiac (123)I-metaiodobenzylguanidine (MIBG) imaging, and the use of a medium-energy (ME) collimator has been shown to improve quantitative accuracy. We investigated the effect of septal penetration on the estimation of H/M ratios using an ME collimator. METHODS AND
RESULTS: Point sources of (99m)Tc and (123)I were imaged using various collimators, which indicated that the effect of high-energy photons with the ME collimator was relatively small but larger than that with the high-energy (HE) collimator. Four hours after (123)I-MIBG injection, 20 patients underwent planar anterior chest imaging by different methods in succession. The ME collimator gave lower H/M ratios (mean 2.52) than the HE collimator (2.57), indicating influence of septal penetration in the ME collimator; however, the difference was limited. Although narrowing the energy window from 20% (2.51) to 15% (2.54) increased the H/M ratios in imaging with the ME collimator, the difference was quite limited.
CONCLUSIONS: Septal penetration affects the estimation of the H/M ratios using an ME collimator; however, this influence is small and would not have clinical significance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24150537     DOI: 10.1007/s12350-013-9804-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

1.  Physical characteristics of low and medium energy collimators for 123I imaging and simultaneous dual-isotope imaging.

Authors:  Y Inoue; I Shirouzu; T Machida; Y Yoshizawa; F Akita; I Doi; T Watadani; M Noda; K Yoshikawa; K Ohtomo
Journal:  Nucl Med Commun       Date:  2003-11       Impact factor: 1.690

Review 2.  Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.

Authors:  Giorgio Treglia; Ernesto Cason
Journal:  J Neuroimaging       Date:  2010-11-17       Impact factor: 2.486

3.  How to use myocardial 123I-MIBG scintigraphy in chronic heart failure.

Authors:  Denis Agostini; Ignasi Carrio; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 9.236

4.  Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies.

Authors:  D J Macey; G L DeNardo; S J DeNardo; H H Hines
Journal:  J Nucl Med       Date:  1986-09       Impact factor: 10.057

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 6.  Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature.

Authors:  Linda van der Veen; Arthur Scholte; Marcel Stokkel
Journal:  Nucl Med Commun       Date:  2010-07       Impact factor: 1.690

7.  Optimal collimator choice for sequential iodine-123 and technetium-99m imaging.

Authors:  F D Geeter; P R Franken; M Defrise; H Andries; E Saelens; A Bossuyt
Journal:  Eur J Nucl Med       Date:  1996-07

Review 8.  Cardiac sympathetic imaging with mIBG in heart failure.

Authors:  Ignasi Carrió; Martin R Cowie; Junichi Yamazaki; James Udelson; Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

9.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

10.  Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

Authors:  Hein J Verberne; Jan B A Habraken; Berthe L F van Eck-Smit; Denis Agostini; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.